Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2018

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Adam M Dubis; Irene Leung; Traci E Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3139. doi:

Clinical Trials October 2017

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial

PDF

Kwadwo Owusu Akuffo; Stephen Beatty; Tunde Peto; Jim Stack; Jim Stringham; David Kelly; Irene Leung; Laura Corcoran; John M. Nolan
TAGS: age-related macular degeneration, antioxidants, carotenoids, clinical trials, vision
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5347-5360. doi: https://doi.org/10.1167/iovs.16-21192

ARVO Annual Meeting Abstract June 2017

Getting to the root of MacTel: joint dissection of genetic risk loci and ocular phenotypes

Roberto Bonelli; Thomas Scerri; Traci E Clemons; Ferenc Sallo; Irene Leung; The MacTel Consortium; Tunde Peto; Melanie Bahlo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):178. doi:

ARVO Annual Meeting Abstract June 2017

Retinal vascular calibres in older HIV-positive men compared to HIV-negative and younger HIV+ controls

Tunde Peto; Lewis Haddow; Irene Leung; Rosanna Laverick; Ian Williams; Jaime Vera; Frank Post; Marta Boffito; Richard Gilson; Alan Winston; Caroline Sabin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1493. doi:

ARVO Annual Meeting Abstract June 2017

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Ferenc B Sallo; Irene Leung; Ute EK Wolf-Schnurrbusch; Bingqian Liu; Kiyoko Gocho; Valerie Krivosic; Tunde Peto; Adam M Dubis; Daniel Pauleikhoff; Traci E Clemons; Michel Paques; Emily Chew; Alain Gaudric; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3687. doi:

ARVO Annual Meeting Abstract September 2016

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial

Traci E Clemons; Emily Y Chew; Tunde Peto; Ferenc B Sallo; Irene Leung

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2038. doi:

ARVO Annual Meeting Abstract September 2016

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Simona Esposti; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4955. doi:

Retina December 2015

Concordance of Macular Pigment Measurement Using Customized Heterochromatic Flicker Photometry and Fundus Autofluorescence in Age-Related Macular Degeneration

PDF

Kwadwo Owusu Akuffo; Stephen Beatty; Jim Stack; Tunde Peto; Irene Leung; Laura Corcoran; Rebecca Power; John M. Nolan
TAGS: age-related macular degeneration, cataract, photometry, photopsia, carotenoids
Invest. Ophthalmol. Vis. Sci.. 2015; 56(13):8207-8214. doi: https://doi.org/10.1167/iovs.15-17822

ARVO Annual Meeting Abstract June 2015

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Tunde Peto; Traci E Clemons; Emily Y Chew; Irene Leung; Ferenc Sallo; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1815. doi:

ARVO Annual Meeting Abstract June 2015

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Vincent Rocco; Meike Zeimer; Britta Heimes; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2783. doi:

ARVO Annual Meeting Abstract April 2014

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Konstantinos Balaskas; Ferenc B Sallo; Irene leung; Traci E Clemons; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4573. doi:

ARVO Annual Meeting Abstract April 2014

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Stela Vujosevic; Ferenc B Sallo; Irene leung; Daniela Ioana Florea; Daniel Pauleikhoff; Traci E Clemons; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5013. doi:

ARVO Annual Meeting Abstract April 2014

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Ferenc B Sallo; Irene Leung; Stela Vujosevic; Traci E Clemons; Alan C Bird; Daniel Pauleikhoff; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5948. doi:

ARVO Annual Meeting Abstract April 2014

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Irene Leung; Ferenc B Sallo; Daniel Pauleikhoff; Alan C Bird; Traci E Clemons; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5950. doi:

ARVO Annual Meeting Abstract April 2014

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Tunde Peto; Stela Vujosevic; Ferenc B Sallo; Daniela Florea; Irene Leung; Traci E Clemons; Emily Y Chew; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):674. doi:

ARVO Annual Meeting Abstract June 2013

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Tunde Peto; Irene Leung; Ferenc Sallo; Catherine Egan; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1531. doi:

ARVO Annual Meeting Abstract June 2013

Subretinal neovascularisation in Macular Telangiectasia type 2: Baseline characteristics and progression over two years

Konstantinos Balaskas; Ferenc Sallo; Irene Leung; Daniela Florea; Alan Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1563. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of main OCT features of Type 2 macular telangiectasia in time- and spectral domain OCTs

Tunde Peto; Irene Leung; Ferenc Sallo; Daniela Florea; Alan Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3604. doi:

ARVO Annual Meeting Abstract March 2012

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

Raeba Mathew; Irene Leung; Ferenc Sallo; Alan C. Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):981. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial

Getting to the root of MacTel: joint dissection of genetic risk loci and ocular phenotypes

Retinal vascular calibres in older HIV-positive men compared to HIV-negative and younger HIV+ controls

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: 48 Month Results from the Phase 1 Safety Trial

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Concordance of Macular Pigment Measurement Using Customized Heterochromatic Flicker Photometry and Fundus Autofluorescence in Age-Related Macular Degeneration

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

Subretinal neovascularisation in Macular Telangiectasia type 2: Baseline characteristics and progression over two years

Comparison of main OCT features of Type 2 macular telangiectasia in time- and spectral domain OCTs

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

To View More...

You must be signed into an individual account to use this feature.